
Daniel R. Wahl
Radiation Oncology
1500 E Medical Center Dr
Floor B2 C490
Ann Arbor, MI 48109
Floor B2 C490
Ann Arbor, MI 48109
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Brain cells refine nitrogen choice with maturity.
Journal: Nature metabolism
Published: April 29, 2026
Adaptive nuclear GTP synthesis promotes glioblastoma treatment resistance and is a targetable vulnerability in patients.
Journal: medRxiv : the preprint server for health sciences
Published: November 26, 2025
Neuronal SEL1L-HRD1 ERAD regulates one-carbon metabolism and is essential for motor function and survival.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Neuronal SEL1L-HRD1 ER-associated degradation is essential for motor function and survival in mice.
Journal: The Journal of clinical investigation
Published: June 17, 2025
A New Tool to Decrease Interobserver Variability in Biomarker Annotation in Solid Tumor Tissue for Spatial Transcriptomic Analysis.
Journal: Current issues in molecular biology
Published: June 12, 2025
Parotid-Sparing Versus Conventional Whole Brain Radiation Therapy: A Multi-Institutional Randomized Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: June 06, 2025
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition.
Journal: Neuro-oncology
Published: April 10, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Journal: Cancer discovery
Published: January 30, 2025
Reciprocal links between methionine metabolism, DNA repair and therapy resistance in glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: December 09, 2024
A Phase 2 Study of Multiparametric Magnetic Resonance Imaging-Guided High-Dose Response-Adaptive Radiation Therapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma: Results From an Interim Analysis.
Journal: International journal of radiation oncology, biology, physics
Published: November 18, 2024
H3K27M enhances basal ATM signaling but is not required for radiosensitization of diffuse midline glioma via ATM inhibition with AZD1390.
Journal: Molecular cancer therapeutics
Published: November 08, 2024
Digital twins for in vivo metabolic flux estimations in patients with brain cancer.
Journal: Cell metabolism
Published: October 24, 2024
Last Updated: 09/26/2026